


Diverse employees at TG Therapeutics have rated CEO Rating, Team, and Work Culture as the highest categories they have scored
Women at TG Therapeutics have rated CEO Rating, Environment, and Work Culture as the highest categories they have scored
TG Therapeutics employees are 0% more likely to recommend TG Therapeutics as a great place to work
| 42% | Promoters |
|---|---|
| 16% | Passives |
| 42% | Detractors |
Working at TG Therapeutics is rated average by 20 employees, across various culture dimensions. TG Therapeutics employees are most satisfied about CEO Rating, Meetings, and Team categories, putting TG Therapeutics’s culture in the Top 40% compared to similar sized companies on Comparably and in the Top 40% compared to other companies in Burlington, NC. See below in detail how working at TG Therapeutics was rated by employees.
Overall Company Culture at TG Therapeutics is rated B-
Last updated today
TG Therapeutics ranks in the Top 40% of other companies on Comparably with 201-500 Employees for Overall Company Culture Score
Share Your Opinion
Anonymously Rate Your Experience & Make Work BetterOut of 24 TG Therapeutics employee reviews, 29% were positive. The remaining 71% were constructive reviews with the goal of helping TG Therapeutics improve their work culture.
| Positive Reviews | 29% |
|---|---|
| Constructive Feedback | 71% |
What is the best part about your compensation package?Pay and stock are the best part of compensation
What is most positive about the culture and environment at your company?Nothing was positive. There was always gossip about other departments and there was always a lot of fake friendly interactions.
What are some of the best things about your team?Everyone is friendly and hardworking
What's going wrong and how can it be improved?There shouldn't be any nepotism
What do your coworkers need to improve and how could you work together better?Working together is better then working against one another.
Why do you feel undervalued and what would make you feel better about your compensation?I was lead to believe to be apart of something great. Working on tasks to the best of my abilities then realizing they were just using me as much as possible.
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.
TG Therapeutics was founded in 2012 and its current CEO is Michael S. Weiss. Since its inception 14 years ago, TG Therapeutics has grown to 350 employees.
TG Therapeutics was founded with one goal in mind – to leverage scientific advances to develop the best possible treatment options for patients. Today, our focus is on translating that deep understanding of B-cells developing therapies for autoimmune diseases, with a current focus on multiple sclerosis (MS). These are conditions in which dysregulated B-cell activity plays a critical role in driving inflammation and tissue damage. By targeting B-cells with precision, our goal is to meaningfully alter the course of disease and improve how treatment fits into patients’ lives.
How We Work: Find the right science early. We identify programs grounded in strong science and a clear therapeutic rationale, then move quickly to generate decisive clinical data. Design for real-world use. We develop therapies that not only work but work better for patients—reducing treatment burden and increasing flexibility. Focus where we can lead. We invest where our expertise can have the greatest impact. Build with partners. We collaborate with scientists, clinicians, and companies worldwide to advance innovative ideas that can help patients sooner.
| Headquarter | 3020 Carrington Mill Blvd. Morrisville, NC 27560-5435 United States of America |
|---|---|
| Website | tgtherapeutics.com |
| Founding Date | 2012 |
| Tel | 1-877-TGTXINC |
| Company Status | Public |
| Stock | TGTX |
| Jobs | www.tgtherapeutics.com/about-us/join-us/ |
| Social Sites |
TG Therapeutics competitors include Biogen. TG Therapeutics ranks 2nd in Overall Culture Score on Comparably vs its competitors. See below how TG Therapeutics compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.

TG Therapeutics has 350 employees. 20 employees at TG Therapeutics have reviewed TG Therapeutics across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was today.
Overall, the 20 TG Therapeutics employees give their leadership a grade of C+, or Top 50% of similar size companies on Comparably. This includes specific ratings of their executive team, CEO, and manager.
Employees at TG Therapeutics are generally satisfied with their total compensation at TG Therapeutics, which includes a combination of pay, stock and equity, and benefits.
Overall, employees at TG Therapeutics are pleased with their team. 20 Participants grade the quality of their coworkers a B. The majority believe the meetings at TG Therapeutics are effective, and the majority look forward to interacting with their coworkers.
The majority of employees at TG Therapeutics believe the environment at TG Therapeutics is positive. Most Participants believe the pace of work at TG Therapeutics is comfortably fast. About 34% of the employees at TG Therapeutics work 8 hours or less, while 8% of them have an extremely long day - longer than twelve hours.
Overall, the employees at TG Therapeutics are happy, based on their aggregated ratings of future outlook, customer perception, and their excitement going to work.


The prevailing opinion from employees about joining TG Therapeutics is that the company was very unprepared on their first day. TG Therapeutics employees concluded that their overall onboarding experience was negative. 50% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
At TG Therapeutics 50% of employees think their department KPIs and OKRs are clear. Employees’ understanding of TG Therapeutics' KPIs and OKRs is essential for its success. Out of 2 TG Therapeutics employees who’ve answered, “Are your company’s goals clear and are you invested in them?” 1 have said yes.
TG Therapeutics’s CEO Michael S. Weiss started in this role in 2011. Michael’s approval rate is in the Top 15% of all CEOs of similar-sized companies on Comparably, and in the Top 20% compared to the CEOs of all other companies in Burlington, NC. TG Therapeutics’s CEO is highly regarded especially by Hispanic or Latino employees, Female employees, and employees with 3 to 6 Years experience. However, Male employees, Caucasian employees, and employees with 1 to 3 Years experience have a less favorable view of the CEO and believe there is room for improvement. Compared to TG Therapeutics’s competitors, Michael S. Weiss ranks right above Biogen CEO Michel Vounatsos. Under S. Weiss’s leadership, TG Therapeutics employee respondents are most happy about their Meetings and the company’s Team. Diversity and Office Culture are two areas, according to respondents, where TG Therapeutics could stand to see real improvement.
The TG Therapeutics Executive Team is rated a “C+” and led by CEO Michael S. Weiss, Chief Communications Officer Jenna Bosco, and Vice President Operations Tim Hillman
Michael S. Weiss CEO / President
Michael S. Weiss has served as TG’s Chairman, President and CEO since December 2011. Mr. Weiss is also currently a... read more
Jenna Bosco Chief Communications Officer
Jenna Bosco serves as the Chief Communications Officer at TG Therapeutics, Inc.
Tim Hillman Vice President Operations
Tim Hillman serves as the Vice President Operations of TG Therapeutics, Inc.. Tim started at TG Therapeutics, Inc. in... read more
Mark Glick VP Program Management
Mark Glick serves as the VP Program Management of TG Therapeutics, Inc.. Mark started at TG Therapeutics, Inc. in Jan of... read more
Adam Waldman Chief Commercial Officer
Adam Waldman joined TG Therapeutics in June of 2018 as the Chief Commercialization Officer. Most recently, Mr. Waldman... read more
Hari Miskin Chief Development Officer
Hari Miskin serves as the Chief Development Officer of TG Therapeutics, Inc.. Hari started at TG Therapeutics, Inc. in... read more
Emmanuel Normant Vice President, Pre-Clinical Sciences
Emmanuel Normant serves as the Vice President, Pre-Clinical Sciences of TG Therapeutics.
Art Faulkner SVP, Regulatory CMC
Art Faulkner serves as the Vice President, Regulatory CMC of TG Therapeutics, Inc.. Art started at TG Therapeutics, Inc.... read more
How much do people at TG Therapeutics get paid? See the latest salaries by department and job title. The average estimated annual salary, including base and bonus, at TG Therapeutics is $117,414, or $56 per hour, while the estimated median salary is $131,401, or $63 per hour.
At TG Therapeutics, the highest paid job is a General Counsel at $272,883 annually and the lowest is a CS Rep at $45,458 annually. Average TG Therapeutics salaries by department include: Admin at $55,532, Sales at $249,432, Engineering at $128,429, and Marketing at $159,991. Half of TG Therapeutics salaries are above $131,401.
16 employees at TG Therapeutics rank their Compensation in the Top 35% of similar sized companies in the US (based on 48 ratings) while 15 employees at TG Therapeutics rank their Perks And Benefits in the Top 50% of similar sized companies in the US (based on 19 ratings).
Last updated a day ago.
| Summary | Salary Range | Percentile |
|---|---|---|
1st Percentile $73k | $73k | 1st Percentile |
20th Percentile $103k | $103k | 20th Percentile |
40th Percentile $121k | $121k | 40th Percentile |
60th Percentile $196k | $196k | 60th Percentile |
80th Percentile $269k | $269k | 80th Percentile |
100th Percentile $348k | $348k | 100th Percentile |
* Estimated salaries Estimated salaries are based on data provided anonymously by employees and/or estimated by other statistical methods.
Diverse employees at TG Therapeutics score the company 54/100 across various culture categories, placing TG Therapeutics in the Bottom 10% of companies on Comparably with 201-500 Employees for Comparably's diversity score. The Diversity score provides insights into how diverse employees feel and rate their work experience at TG Therapeutics across various culture dimensions.
TG Therapeutics' PTO and Vacation policy typically gives 15-20 days off a year with 50% of employees expected to be work free while out of office. TG Therapeutics' benefits and PTO Package averages to represent a $500 -$1000 cash value per month.

No Recent Jobs found for TG Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

Candidates By Department
Engineering | 50% | |
|---|---|---|
All Industries | 50% |
Candidates By Location
Chandler | 50% | |
|---|---|---|
Seattle | 50% |
What is TG Therapeutics address?
TG Therapeutics location is at 3020 Carrington Mill Blvd.
Who is the CEO of TG Therapeutics?
TG Therapeutics CEO is Michael S. Weiss, their score by employees is 76
What is the salary for Technical Support in TG Therapeutics?
Technical Support average salary in the US is 60k
What are the salaries in the Marketing in TG Therapeutics?
The average salaries for Marketing in TG Therapeutics is 160k
How many employees work in TG Therapeutics?
TG Therapeutics has 350 employees